Related Experiment Video
Updated: Aug 29, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative
Nadia Güell1, Pablo Mozas2, Alba Jimenez-Rueda1,3
1Hematology Laboratory, Unitat de citometria ICO-Badalona (CITICOB), Hospital Germans Trias i Pujol, IJC, LUMN, Universitat Autònoma de Barcelona, Badalona, Spain.
Insights
Diagnosing leukemic B-cell lymphoproliferative disorders (B-LPDs) requires integrating multiple data types, but inconsistencies persist. This study identifies methodological and conceptual factors in flow cytometry that hinder reproducible B-LPD diagnosis.
Area of Science:
- Hematology
- Immunology
- Pathology
Background:
- Diagnosis of leukemic B-cell lymphoproliferative disorders (B-LPDs) relies on integrating diverse data, including clinical, cytological, cytometric, cytogenetic, and molecular information.
- Current diagnostic approaches are susceptible to inter-expert variability and inconsistencies.
- Flow cytometry is a key technique in B-LPD diagnosis, but its application presents challenges.
Purpose of the Study:
- To examine methodological and conceptual factors contributing to inconsistencies in the flow cytometric classification of leukemic B-LPDs.
- To identify areas for improvement in diagnostic reproducibility and interobserver agreement.
- To discuss harmonization efforts and propose a path forward for reliable B-LPD diagnosis.
Main Methods:
- Analysis of methodological aspects: statistical tests for marker selection/evaluation, marker analysis techniques, score interpretation, utilization of diagnostic information, and impact of study populations.
- Examination of conceptual aspects: integration of diverse biological data, costs of misclassification (false positives/negatives), and the absence of a definitive diagnostic gold standard.
- Review of current harmonization initiatives and expert approaches.
Main Results:
- Numerous flow cytometry scoring systems and diagnostic frameworks exist for B-LPDs.
- Methodological variations in statistical analysis, marker interpretation, and population differences impact diagnostic consistency.
- Conceptual challenges in data integration and the lack of a gold standard contribute to poor diagnostic reproducibility.
Conclusions:
- Achieving external reproducibility and interobserver agreement in B-LPD diagnosis requires addressing identified methodological and conceptual issues.
- The development and validation of a true diagnostic gold standard are crucial for advancing the field.
- Harmonization efforts are underway, but significant challenges remain in standardizing flow cytometric classification of B-LPDs.
Abstract:
The diagnosis of leukemic B-cell lymphoproliferative disorders (B-LPDs) is made by integrating clinical, cytological, cytometric, cytogenetic, and molecular data. This leaves room for differences and inconsistencies between experts. In this study, we examine methodological and conceptual aspects of the flow cytometric classification of leukemic B-LPDs that could explain them. Among methodological aspects, we discuss (1) the different statistical tests used to select and evaluate markers, (2) how these markers are analyzed, (3) how scores are interpreted, (4) different degrees to which diagnostic information is used, and (5) and the impact of differences in study populations. Among conceptual aspects, we discuss (1) challenges to integrating different biological data points, (2) the under examination of the costs of misclassification (false positives and false negatives), and finally, (3) we delve into the impact of the lack of a true diagnostic gold standard and the indirect evidence suggesting poor reproducibility in the diagnosis of leukemic B-LPDs. We then outline current harmonization efforts and our personal approach. We conclude that numerous flow cytometry scores and diagnostic systems are now available; however, as long as the considerations discussed remain unaddressed, external reproducibility and interobserver agreement will not be achieved, and the field will not be able to move forward if a true gold standard is not found.
Related Concept Videos
Flow Cytometry
In...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

